ABL1 and neuroblastoma: The results demonstrate that high expression of both ABL and SRC genes predict lower overall and relapse-free survival in the Versteeg-88 dataset (Figure 3A-3B), which suggests that expression levels of both Src and c-Abl tyrosine kinases could be used as predictive markers for the outcomes of NB patients.